本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Protalix BioTherapeutics Inc

2.77
+0.13004.92%
盤後2.780.0145+0.52%19:30 EDT
成交量:95.22萬
成交額:260.87萬
市值:2.23億
市盈率:11.72
高:2.79
開:2.63
低:2.62
收:2.64
52周最高:3.19
52周最低:1.60
股本:8,042.12萬
流通股本:7,653.64萬
量比:1.26
換手率:1.24%
股息:- -
股息率:- -
每股收益(TTM):0.2364
每股收益(LYR):-0.0841
淨資產收益率:31.23%
總資產收益率:15.42%
市淨率:3.12
市盈率(LYR):-32.95

資料載入中...

2021/07/30

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/07/07

重要事件披露

8-K - Current report
2021/07/02

重要事件披露

8-K - Current report
2021/06/30

重要事件披露

8-K - Current report
2021/06/15

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/06/02

重要事件披露

8-K - Current report
2021/05/14

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/05/14

重要事件披露

8-K - Current report
2021/04/30

[修訂]年度報告

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/04/28

重要事件披露

8-K - Current report
2021/03/30

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/03/30

重要事件披露

8-K - Current report
2021/02/23

重要事件披露

8-K - Current report
2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

重要事件披露

8-K - Current report
2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/09

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/08

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/08

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals